Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung Cancer

Clinical trial NCT01809210 · COMPLETED

Trial details

NCT number

NCT01809210

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-04-04

Primary completion

2016-01-04

Enrollment

55

View on ClinicalTrials.gov